Objective: Refractory status epilepticus is a serious condition in which seizure continues despite use of two antiepileptic medications. Retrospective studies have shown that 29%-43% of SE patients progress into RSE despite treatment. Mortality following RSE is high. We aimed to evaluate the predictors of outcome in patients with RSE at a tertiary care center. Methods: Sixty-eight consecutive patients with RSE who presented to our hospital between February 2018 and January 2020 were evaluated for outcome. Result: In our study 28(41.2%), patients who failed to respond to first- and second-line antiepileptic drug responded to the third-line antiepileptic drug thus avoiding mechanical ventilation and intravenous anesthesia. Low GCS at admission (P
CITATION STYLE
Kafle, D. R., Avinash, A. J., & Shrestha, A. (2020). Predictors of outcome in refractory generalized convulsive status epilepticus. Epilepsia Open, 5(2), 248–254. https://doi.org/10.1002/epi4.12394
Mendeley helps you to discover research relevant for your work.